Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Tissue bridges linked with short, long-term benefits in those with spinal cord injury
Implementation of tissue bridges measured within the first weeks after spinal cord injury are linked with short-and-long-term clinical improvement, according to research from The Lancet Neurology.
Protect a physician’s most valuable asset with disability insurance
Given the substantial investment to become a practicing physician, it should not be surprising that the most significant asset of most physicians is their ability to practice their profession.
Log in or Sign up for Free to view tailored content for your specialty!
Patients with sleep apnea, nighttime hypoxemia face elevated late-onset epilepsy risk
Nocturnal hypoxemia and sleep apnea raised the risk for late-onset epilepsy even after adjustment for several risk factors and comorbidities, according to results published in Sleep.
Monoclonal antibody for FSHD improves muscle strength with no serious adverse events
Avidity Biosciences Inc. has announced positive data from the phase 1/2 FORTITUDE clinical trial of a proprietary monoclonal antibody that binds to the transferrin receptor 1 conjugated with a siRNA targeting DUX4 mRNA.
Narcolepsy tied to elevated risk for heart disease, regardless of sleep apnea status
People with narcolepsy were more likely than propensity score-matched people without narcolepsy to develop heart disease, regardless of sleep apnea status, according to a retrospective cohort study.
VIDEO: Antibiotics linked to exacerbation of myasthenia gravis
DENVER — The use of several common antibiotics led to exacerbation of myasthenia gravis in a small cohort of patients, Sanem P. Uysal, MD, said in this Healio video from the American Academy of Neurology annual meeting.
Results positive in study of antisense oligonucleotide for Huntington’s disease
Wave Life Sciences has announced positive results from its phase 1b/2a clinical trial of WVE-003, a potential disease-modifying therapeutic for Huntington’s disease.
Patients with migraine report superior outcomes with ubrogepant compared to triptans
SAN DIEGO — Those with migraine who switched from an oral triptan to ubrogepant reported superior outcomes compared with patients who chose another triptan,, according to data presented at the American Headache Society Annual Scientific Meeting.
Children with MIS-C or COVID-19 and severe neuro symptoms face long-term impairment risk
Children hospitalized with SARS-CoV-2 or an inflammatory syndrome associated with SARS-CoV-2 infection who experience severe neurological manifestations may be at a higher risk for long-term impairment, a study found.
Q&A: SAGE test catches cognitive impairment early in a ‘critical time’
A self-administered assessment tool was effective in identifying cognitive impairment vs. routine care in primary care settings, according to results recently published in Frontiers in Medicine.
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read